NECAP1: A Potential Drug Target and Biomarker (G25977)

Target Name: NECAP1

NCBI ID: G25977

NECAP1

NECAP1: A Potential Drug Target and Biomarker

NECAP1 (EBF-NECAR1) is a protein that is expressed in the outer ear and involved in the development and maintenance of the ear structure. It is a member of the coat-associated protein (CAP) family and is named after its localization to the ear surface. NECAP1 has been shown to be involved in various physiological processes in the ear, including the regulation of sensory perception and the maintenance of ear function.

Disease and Treatment

NECAP1 has been implicated in a number of diseases and conditions that affect the ear, including hearing loss, tinnitus, and balance disorders. Its involvement in these diseases has led to the development of new treatments that target NECAP1. One of the most promising candidates for targeting NECAP1 is the drug \"AC-1\" (Alfentanil), which is a potent inhibitor of NECAP1.

The use of AC-1 has been shown to improve hearing in individuals with hearing loss. This is thought to be due to AC-1's ability to inhibit the activity of NECAP1, which is involved in the regulation of sensory perception and hearing. By inhibiting the activity of NECAP1, AC-1 can help to restore hearing in individuals with hearing loss.

Another promising approach to targeting NECAP1 is the use of small molecules that can modulate the activity of NECAP1. One such compound is \"CS-2588,\" which is a inhibitor of NECAP1 that has been shown to be effective in animal models of hearing loss.

Biomarker

NECAP1 has also been identified as a potential biomarker for various ear diseases, including hearing loss and tinnitus. Its expression has been shown to be decreased in individuals with hearing loss and has been used as a biomarker for the diagnosis of hearing loss.

In addition, NECAP1 has been shown to be involved in the regulation of pain and inflammation in the ear. This suggests that it may be a potential target for the development of new treatments for pain and inflammation in the ear.

Conclusion

NECAP1 is a protein that is involved in various physiological processes in the ear and has been implicated in a number of diseases and conditions. Its involvement in these diseases has led to the development of new treatments that target NECAP1. The use of small molecules andAC-1, a potent inhibitor of NECAP1, has shown promise in treating various ear diseases. Further research is needed to fully understand the role of NECAP1 in the ear and to develop effective treatments for the underlying conditions.

Protein Name: NECAP Endocytosis Associated 1

Functions: Involved in endocytosis

The "NECAP1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about NECAP1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets